Fundraising Fox

Greg Banker

Investor

Vice President at Vensana Capital

Minneapolis, Minnesota

Writes $10M – $40M checks · typically $25M

FoundedArtelonTYBR Health · YC

About

Greg Banker combines operator-heavy medtech experience—he led Strategic Market Development at Vertiflex through its 2019 Boston Scientific exit, advised CEOs on 20+ market assessments, and sits on medtech device boards.

Invests in

AI & Machine LearningBiotechData & InfrastructureHealthtechMedical Devices

Experience

  1. Vensana CapitalPartnercurrent2024 — present
  2. Vensana CapitalVice President2021 — 2023
  3. Vensana CapitalSenior Associate2019 — 2021
  4. VertiflexDirector, Strategic Market Development2018 — 2019
  5. NavigantAssociate Director2018
  6. NavigantManaging Consultant2016 — 2018
  7. NavigantSenior Consultant2016
  8. NavigantConsultant2014 — 2015
  9. R&D SystemsResearch Associate2011 — 2012

Education

  1. University of Minnesota Medical SchoolMedical Student2012 — 2014
  2. University of Wisconsin-MadisonB.S., Biology2007 — 2011

Skills & more

Strategic PlanningStrategyLeadership1Management1Public SpeakingBiotechnology3Data Analysis5Research3Technical Writing2Life Sciences1Healthcare1Medical Devices3
+12 moreEpidemiologyMarket DevelopmentMarket ResearchBiomedical ResearchManagement ConsultingMarket SegmentationBusiness StrategyProject ManagementBusiness DevelopmentAnalyticsInvestmentsFinance

From Greg's professional profile.

Same school

Shared employers

Deals · 1

TYBR HealthBoard seat

via Vensana Capital · filed Jul 2026 · $30M raise

press ↗

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Vensana Capital

Network2

Investors connected to Greg in public investor directories — a warm-intro map.